| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9839f6d12a5811cfe613bc363f3a068 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3523d1e2b8bbe1b5b2ceedf92ab1cfe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ff9540c678861f8df350616d487f987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_622f43bdab72f2837ab11eeb6008b4a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4a66238066fd123903e27d2e6f0000d |
| publicationDate |
2022-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3936132-A1 |
| titleOfInvention |
Azelastine as antiviral treatment |
| abstract |
An Azelastine compound in an antiviral effective amount for use as an antiviral substance in a pharmaceutical preparation for use in prophylactic or therapeutic treatment of a subject in need of antiviral treatment. |
| priorityDate |
2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |